<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="116417-2018"
            EDITION="2018052">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-117847-001</RECEPTION_ID>
      <DELETION_DATE>20190313</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>52</NO_OJ>
         <DATE_PUB>20180315</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 052-116417</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:116417-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="NO"/>
         <IA_URL_GENERAL>https://permalink.mercell.com/82273165.aspx</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33650000">General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="NO01">Oslo og Akershus</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="NO">NORGE</n2016:CA_CE_NUTS>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180313</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="0">Prior information notice without call for competition</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="9">Not applicable</PR_PROC>
         <RP_REGULATION CODE="B">European Economic Area (EEA), with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="9">Not applicable</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>03B01</HEADING>
         <INITIATOR>03</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Норвегия</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Общи противовъзпалителни средства за системна употреба, ваксини, антинеопласти и имуномодулатори</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Norsko</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva pro systémové užití, očkovací látky, antineoplastika a imunomodulátory</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektive midler til systemisk brug, vacciner, cytostatike/cytotoxiske midler samt immunmodulerende midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Norwegen</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva zur systemischen Anwendung, Impfstoffe, Antineoplastika und Immunmodulatoren</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Νορβηγία</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Φάρμακα κατά των λοιμώξεων συστηματικής χρήσης, εμβόλια, αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Norway</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Norra</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Üldised infektsioonivastased ained süsteemseks kasutamiseks, vaktsiinid, antineoplastilised ja immuunmoduleerivad ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Norja</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Norvège</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infectieux généraux à usage systémique, vaccins, antinéoplasiques et immunomodulateurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Iorua, an</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Opća protuupalna sredstva za sustavno liječenje, cjepiva, antineoplastična sredstva i imunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Norvégia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Általános fertőzésellenes szerek szisztémás használatra, vakcinák, daganatellenes és immunmodulátor szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antinfettivi generali per uso sistemico, vaccini, agenti antineoplastici e immunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Norvegija</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Sistemiškai veikiantys priešinfekciniai vaistai, vakcinos, antinavikiniai vaistai ir imunomoduliatoriai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Norvēģija</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Vispārēji pretinfekcijas līdzekļi sistēmiskai lietošanai, vakcīnas, antineoplastiskie līdzekļi un imūnmodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>in-Norveġja</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infettivi ġenerali għall-użu sistematiku, vaċċini, antineoplastika u aġenti immunomodulaturi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Noorwegen</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Algemene infectiewerende middelen voor systemisch gebruik, vaccins, antineoplastica en immunomodulerende middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Norwegia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecţioase generale pentru uz sistemic, vaccinuri, antineoplazice şi imunomodulatoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nórsko</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Všeobecné antiinfekčné látky na systémové použitie, očkovacie látky, antineoplastické prostriedky a imunomodulačné činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antimikotiki za sistemsko zdravljenje, cepiva, zdravila z delovanjem na novotvorbe in imunomodulatorji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva medel för systemiskt bruk, vacciner, cytostatika/cytotoxiska medel, samt immunmodulerande medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Sykehusinnkjøp HF</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F01_2014 CATEGORY="ORIGINAL" FORM="F01" LG="EN">
         <NOTICE TYPE="PRI_ONLY"/>
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Sykehusinnkjøp HF</OFFICIALNAME>
               <NATIONALID>916879067</NATIONALID>
               <ADDRESS>Postboks 40</ADDRESS>
               <TOWN>Vadsø</TOWN>
               <POSTAL_CODE>9811</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <CONTACT_POINT>Carola Marie Sommevåg</CONTACT_POINT>
               <E_MAIL>carola.marie.sommevag@sykehusinnkjop.no</E_MAIL>
               <n2016:NUTS CODE="NO"/>
               <URL_GENERAL>https://permalink.mercell.com/82273165.aspx</URL_GENERAL>
               <URL_BUYER>http://www.sykehusinnkjop.no/</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <ADDRESS_FURTHER_INFO>
               <OFFICIALNAME>Mercell Norge AS</OFFICIALNAME>
               <ADDRESS>Karihaugveien 89</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>1086</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <E_MAIL>support@mercell.com</E_MAIL>
               <n2016:NUTS CODE="NO"/>
               <URL_GENERAL>https://permalink.mercell.com/82273165.aspx</URL_GENERAL>
            </ADDRESS_FURTHER_INFO>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT ITEM="1">
            <TITLE>
               <P>LIS 1907 a-b Oncology, various chemo therapeutics Prior information notice - market dialogue</P>
            </TITLE>
            <REFERENCE_NUMBER>2018/229</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33650000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Tenderers are invited to a market dialogue for a new procurement within 1907 a-b Oncology, various chemo therapeutics. Information about the market dialogue is attached the notice.</P>
            </SHORT_DESCR>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <n2016:NUTS CODE="NO01"/>
               <SHORT_DESCR>
                  <P>Parts from the previous competition 1807 are to be re-announced. These are the active ingredient from 1 807 g Various peroral administered chemo therapeutics and 1 807 j Various chemo therapeutics for injection and infusion as well as some other oncological active ingredients. These areas have been merged to 1907 a-b Oncology, various chemo therapeutics.</P>
               </SHORT_DESCR>
            </OBJECT_DESCR>
            <DATE_PUBLICATION_NOTICE>2018-06-18</DATE_PUBLICATION_NOTICE>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <CONTRACT_COVERED_GPA/>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <DATE_DISPATCH_NOTICE>2018-03-13</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F01_2014>
   </FORM_SECTION>
</TED_EXPORT>
